Cappello P[au] - Search Results

Year	Number of Results
1958	1
1959	1
1981	1
1985	2
1998	1
1999	3
2000	1
2002	1
2003	3
2004	4
2005	3
2006	2
2007	1
2008	5
2009	2
2010	5
2011	4
2012	2
2013	9
2014	3
2015	5
2016	10
2017	7
2018	9
2019	4
2020	6
2021	8
2022	1

1

Alpha-Enolase (ENO1), a potential target in novel immunotherapies.

Cappello P, Principe M, Bulfamante S, Novelli F. Cappello P, et al. Front Biosci (Landmark Ed). 2017 Jan 1;22:944-959. doi: 10.2741/4526. Front Biosci (Landmark Ed). 2017. PMID: 27814656 Free article. Review.

2

Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth.

Li M, Sala V, De Santis MC, Cimino J, Cappello P, Pianca N, Di Bona A, Margaria JP, Martini M, Lazzarini E, Pirozzi F, Rossi L, Franco I, Bornbaum J, Heger J, Rohrbach S, Perino A, Tocchetti CG, Lima BHF, Teixeira MM, Porporato PE, Schulz R, Angelini A, Sandri M, Ameri P, Sciarretta S, Lima-Júnior RCP, Mongillo M, Zaglia T, Morello F, Novelli F, Hirsch E, Ghigo A. Li M, et al. Among authors: cappello p. Circulation. 2018 Aug 14;138(7):696-711. doi: 10.1161/CIRCULATIONAHA.117.030352. Circulation. 2018. PMID: 29348263

3

Next generation of cancer immunotherapy calls for combination.

Cappello P, Novelli F. Cappello P, et al. Oncoscience. 2017 Mar 31;4(3-4):19-20. doi: 10.18632/oncoscience.343. eCollection 2017 Mar. Oncoscience. 2017. PMID: 28540328 Free PMC article. No abstract available.

4

Soluble stroma-related biomarkers of pancreatic cancer.

Resovi A, Bani MR, Porcu L, Anastasia A, Minoli L, Allavena P, Cappello P, Novelli F, Scarpa A, Morandi E, Falanga A, Torri V, Taraboletti G, Belotti D, Giavazzi R. Resovi A, et al. Among authors: cappello p. EMBO Mol Med. 2018 Aug;10(8):e8741. doi: 10.15252/emmm.201708741. EMBO Mol Med. 2018. PMID: 29941541 Free PMC article.

5

Discovery of Targets for Cancer Immunoprevention.

Cappello P, Bulfamante S, Mandili G, Novelli F. Cappello P, et al. Methods Mol Biol. 2022;2435:19-33. doi: 10.1007/978-1-0716-2014-4_3. Methods Mol Biol. 2022. PMID: 34993937

6

α-Enolase: a promising therapeutic and diagnostic tumor target.

Capello M, Ferri-Borgogno S, Cappello P, Novelli F. Capello M, et al. Among authors: cappello p. FEBS J. 2011 Apr;278(7):1064-74. doi: 10.1111/j.1742-4658.2011.08025.x. Epub 2011 Feb 24. FEBS J. 2011. PMID: 21261815 Free article. Review.

7

Molecular and genetic bases of pancreatic cancer.

Vaccaro V, Gelibter A, Bria E, Iapicca P, Cappello P, Di Modugno F, Pino MS, Nuzzo C, Cognetti F, Novelli F, Nistico P, Milella M. Vaccaro V, et al. Among authors: cappello p. Curr Drug Targets. 2012 Jun;13(6):731-43. doi: 10.2174/138945012800564077. Curr Drug Targets. 2012. PMID: 22458519 Free article. Review.

8

Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners.

Cappello P, Curcio C, Mandili G, Roux C, Bulfamante S, Novelli F. Cappello P, et al. Cancers (Basel). 2018 Feb 16;10(2):51. doi: 10.3390/cancers10020051. Cancers (Basel). 2018. PMID: 29462900 Free PMC article. Review.

9

Death receptor ligands in tumors.

Cappello P, Novelli F, Forni G, Giovarelli M. Cappello P, et al. J Immunother. 2002 Jan-Feb;25(1):1-15. doi: 10.1097/00002371-200201000-00001. J Immunother. 2002. PMID: 11924906 Review.

10

The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer.

Curcio C, Brugiapaglia S, Bulfamante S, Follia L, Cappello P, Novelli F. Curcio C, et al. Among authors: cappello p. Molecules. 2021 Mar 15;26(6):1642. doi: 10.3390/molecules26061642. Molecules. 2021. PMID: 33804240 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results